Ikonisys
Developer of automated fluorescence in situ hybridization (FISH) imaging systems and a clinical genetic testing platform for cancer diagnostics. The company documents clinical applications for diagnosis, prognosis, therapy-response prediction and surveillance, reports extensive real-world validation of its genetic testing platform, and describes integration of automated FISH with cytology workflows for screening.
Industries
Nr. of Employees
medium (51-250)
Patents
Products
Automated FISH microscope system
An automated fluorescence microscopy system intended to perform FISH slide scanning and image capture to support cytogenetic testing workflows.
Ikoniscope20
Fully-automated fluorescence microscopy solution designed to meet the rigorous demands of high-throughput laboratories with a capacity of up to 160 slides per instrument.
Ikoniscope20max
Fully-automated fluorescence microscopy solution designed to meet the rigorous demands of high-throughput laboratories with a capacity of up to 160 slides per instrument.
A unique fully-automated solution for diagnostics laboratories Revolutionizing laboratories’ workflow through full automation
A fully-automated high-speed Fluorescence Microscopy Platform optimized for the identification, analysis and enumeration of rarecells in a biological sample.
Ikoniscope
A fully-automated high-speed Fluorescence Microscopy Platform optimized for the identification, analysis and enumeration of rare cells in a biological sample.
IkoniWAN Gateway
Validated remote access solution for Ikoniscope digital microscopy systems allowing secure connection from any location with standard internet connectivity.
Automated FISH microscope system
An automated fluorescence microscopy system intended to perform FISH slide scanning and image capture to support cytogenetic testing workflows.
Ikoniscope20
Fully-automated fluorescence microscopy solution designed to meet the rigorous demands of high-throughput laboratories with a capacity of up to 160 slides per instrument.
Ikoniscope20max
Fully-automated fluorescence microscopy solution designed to meet the rigorous demands of high-throughput laboratories with a capacity of up to 160 slides per instrument.
A unique fully-automated solution for diagnostics laboratories Revolutionizing laboratories’ workflow through full automation
A fully-automated high-speed Fluorescence Microscopy Platform optimized for the identification, analysis and enumeration of rarecells in a biological sample.
Ikoniscope
A fully-automated high-speed Fluorescence Microscopy Platform optimized for the identification, analysis and enumeration of rare cells in a biological sample.
IkoniWAN Gateway
Validated remote access solution for Ikoniscope digital microscopy systems allowing secure connection from any location with standard internet connectivity.
Services
Provision of diagnostic workflows and solutions combining FISH-based cytogenetics with cytology for cancer diagnosis, prognosis, therapy prediction, and surveillance.
Automated fluorescence imaging systems for FISH workflows, including imaging hardware and associated validated workflows for diagnostic use.
Provision of diagnostic workflows and solutions combining FISH-based cytogenetics with cytology for cancer diagnosis, prognosis, therapy prediction, and surveillance.
Automated fluorescence imaging systems for FISH workflows, including imaging hardware and associated validated workflows for diagnostic use.
Expertise Areas
- Cytogenetic diagnostics (FISH)
- Automated fluorescence microscopy and imaging hardware
- Clinical genetic testing platform validation
- Digital pathology and image analysis for FISH
Key Technologies
- Fluorescence in situ hybridization (FISH)
- Automated fluorescence microscopy
- Automated slide scanning
- Digital image analysis for pathology
News & Updates
Event text references a new lab opening and the combination of liquid-based cytology with automated FISH testing for bladder cancer mass screening.
Conference listing with date and venue information (18 August 2017, Vodafone Centre, London).
The site states the genetic testing platform has undergone extensive validation in thousands of real-world scenarios, reporting consistent and accurate results across a wide range of conditions.
Event text references a new lab opening and the combination of liquid-based cytology with automated FISH testing for bladder cancer mass screening.
Conference listing with date and venue information (18 August 2017, Vodafone Centre, London).
The site states the genetic testing platform has undergone extensive validation in thousands of real-world scenarios, reporting consistent and accurate results across a wide range of conditions.